ZERO WORLD RESEARCHアミノ酸・有機酸の学術文献データベース

Ups and downs in the experimental treatment of murine typhoid fever using gentamicin combined with caffeine.

Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2026de Souza Silva E, Dos Santos Rocha RT, da Silva JNG, et al.
研究デザインその他の原著論文
対象動物

抄録

This study assessed whether combining the aminoglycoside gentamicin with caffeine enhances antimicrobial efficacy in a murine typhoid model. We infected murine peritoneal macrophages in vitro with Salmonella enterica serovar Typhimurium and treated them for 24 h with non-toxic concentrations of caffeine (0.05–5 µg/ml) plus gentamicin (10 µg/ml). Subsequently, Swiss mice were orally challenged with S. Typhimurium and received daily intraperitoneal doses of caffeine (0.05-5 mg/kg) plus gentamicin (10 mg/kg) for five days post-infection. Macrophages treated with 5 µg/ml caffeine plus 10 µg/ml gentamicin exhibited significantly higher viability and a marked reduction in intracellular bacterial load. Lower caffeine doses (0.05 and 0.5 µg/ml) failed to preserve cell viability due to uncontrolled bacterial proliferation. Mice receiving gentamicin – either alone or combined with 5 mg/kg caffeine – showed reduced hepatic bacterial burdens and milder histopathological damage. Notably, only the higher caffeine dose enhanced gentamicin’s efficacy; lower caffeine concentrations antagonized the antibiotic’s activity.

MeSH

AnimalsAnti-Bacterial AgentsBacterial LoadCaffeineDisease Models, AnimalDrug Therapy, CombinationGentamicinsLiverMacrophages, PeritonealMiceSalmonella typhimuriumTyphoid Fever

DOI 10.1007/s42770-026-01948-2

PMID 42043631

原文・出典を見る →